Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1

about

Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1

Item

http://www.wikidata.org/entity/Q58790080

description

scientific article published on 10 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Osteoclast Immunosuppressive E ...... Programmed Cell Death Ligand 1

@en

Osteoclast Immunosuppressive E ...... Programmed Cell Death Ligand 1

@nl

type

Item

label

Osteoclast Immunosuppressive E ...... Programmed Cell Death Ligand 1

@en

Osteoclast Immunosuppressive E ...... Programmed Cell Death Ligand 1

@nl

prefLabel

Osteoclast Immunosuppressive E ...... Programmed Cell Death Ligand 1

@en

Osteoclast Immunosuppressive E ...... Programmed Cell Death Ligand 1

@nl

P1476

Osteoclast Immunosuppressive E ...... Programmed Cell Death Ligand 1

@en

P2093

Kenneth C Anderson

http://www.w3.org/2001/XMLSchema#string

Yu-Tzu Tai

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

The PD-1 pathway in tolerance and autoimmunity

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Osteoimmunology: interactions of the bone and immune system

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

Denosumab: mechanism of action and clinical outcomes

Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche.

P304

1822

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.01822

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shih-Feng Cho

P577

2018-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30147691

http://www.w3.org/2001/XMLSchema#string

P921

membrane proteins

multiple myeloma

hemic and immune systems

Achyolli

P932

6095980

http://www.w3.org/2001/XMLSchema#string